Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: A case report

被引:5
|
作者
Tucker M.G. [1 ]
Kekulawala S. [1 ]
Kent M. [1 ]
Mostafa S. [2 ]
Harvey R. [1 ,3 ]
机构
[1] Mental Health, Drugs and Alcohol Service, Barwon Health, University Hospital Geelong, Geelong, VIC
[2] GenesFX Health, North Melbourne, VIC
[3] School of Medicine, Deakin University, Waurn Ponds, VIC
关键词
Medication safety; Methamphetamine; Pharmacogenetic testing; Psychiatric emergencies; Rapid sedation; Substance-induced psychosis;
D O I
10.1186/s13256-016-1031-3
中图分类号
学科分类号
摘要
Background: The high prevalence of comorbid illicit drug use in persons with chronic psychotic illness represents a strong determinant of psychotic relapse and rehospitalization. Epidemiological studies indicate changing patterns of illicit drug use in Australia, which are concerning because of increased use of crystal methamphetamine, also known as "ice." An important complication of habitual use of crystal methamphetamine is the development of a dose-dependent acute psychotic reaction. We report a case of an acute psychotic relapse in response to polydrug use most notable for multiple recent binges of crystal methamphetamine. Unlike previously described case reports, our patient's acute psychosis was refractory to ultra-high doses of multiple antipsychotic medications. This presented safety challenges due to the risk of serious side effects with high-dose antipsychotic medications. Case presentation: A 30-year-old white man with a past history of schizoaffective disorder was brought to our emergency department by the police in a state of extreme agitation, combativeness, and paranoia after use of cannabis and crystal methamphetamine. Despite existing compliance with zuclopenthixol decanoate depot medication, he required multiple emergency injections of zuclopenthixol acetate, and regular high-dose droperidol, chlorpromazine, and lorazepam. However, he remained severely agitated and psychotic with continuous threats of harm to others. A test of antipsychotic drug metabolism by cytochrome P450 enzymes did not reveal a pharmacogenetic cause for the poor therapeutic efficacy of antipsychotic medications. His psychosis did not appear to be modified by psychoactive medications but was instead self-limited to the presence of endogenous methamphetamine within his system. He fully recovered 96 to 120 hours post-presentation and was discharged home with out-patient clinic follow-up. Conclusions: The current case highlights the challenging nature of a severe psychotic relapse precipitated by illicit substances that is resistant to medical management. High doses of multiple antipsychotic medications may be required to manage dangerous behaviors associated with these acute psychotic relapses. These patients require close monitoring for adverse effects with adjustment of dosing to ensure the optimal balance of risk versus benefit while the patient is acutely psychotic. The results are of relevance for the management of psychiatric emergencies in emergency departments and acute mental health settings. © 2016 The Author(s).
引用
收藏
相关论文
共 50 条
  • [31] A CASE OF MANIA INDUCED BY HIGH-DOSE FLUOXETINE TREATMENT
    CHOUINARD, G
    STEINER, W
    AMERICAN JOURNAL OF PSYCHIATRY, 1986, 143 (05): : 686 - 686
  • [32] Management of Drug-Induced Psoriasis With Secukinumab in a Patient With Schizoaffective Disorder: A Case Report
    Ayub, Ibraheim
    Ayub, Shehzad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [33] TREATMENT OF SEVERE SLEEP DISORDER RELATED TO ALCOHOL-DEPENDENCE WITH HIGH-DOSE AGOMELATINE - A CASE REPORT
    Grosshans, Martin
    Mutschler, Jochen
    Kiefer, Falk
    PSYCHIATRIA DANUBINA, 2013, 25 (04) : 416 - 418
  • [34] Very high-dose methylprednisolone for treatment of nivolumab-induced limbic encephalitis: A case report
    Taillefer, Vincent-Thierry
    Pigeon, Marjorie
    Chen, Michelle
    Larochelle, Catherine
    Florescu, Marie
    Belanger, Karl
    Adam, Jean-Philippe
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (06) : 1538 - 1543
  • [35] High-dose methylprednisolone with chemotherapy for invasive thymoma: A case report
    Hayashi, Mitsutoshi
    Taira, Manako
    Yamawaki, Isao
    Ohkawa, Shin-Ichiro
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3645 - 3648
  • [36] Enhanced Interaction betweenWarfarin and High-Dose Ketoconazole: A Case Report
    Jackevicius, Cynthia A.
    Ton, Mannhu N.
    CASE REPORTS IN MEDICINE, 2009, 2009
  • [37] High-dose radiation-induced meningioma in children - Case report and critical review of the literature
    Caroli, E
    Salvati, M
    Roperto, R
    D'Andrea, G
    Ferrante, L
    ZENTRALBLATT FUR NEUROCHIRURGIE, 2005, 66 (01): : 39 - 42
  • [38] Liver Injury Induced by High-Dose Methylprednisolone Therapy: A Case Report and Brief Review of the Literature
    Gutkowski, Krzysztof
    Chwist, Alina
    Hartleb, Marek
    HEPATITIS MONTHLY, 2011, 11 (08) : 656 - 661
  • [39] High-Dose Tacrolimus-Induced Acute Pancreatitis After Kidney Transplantation: A Case Report
    Peng, Mengyuan
    Lin, Tianjiao
    Song, Zhimin
    Huang, Tao
    Pan, Xinting
    PANCREAS, 2025, 54 (01) : e73 - e74
  • [40] Treatment of Binge Eating Disorder With High-Dose Baclofen A Case Series
    de Beaurepaire, Renaud
    Joussaume, Bernard
    Rapp, Annie
    Jaury, Philippe
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (03) : 357 - 359